Author Archives: wpadmin

Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »

Acupressure Helps Relieve Breast Cancer Treatment Symptoms (STUDY)

A study has found that acupressure could be a low-cost, DIY solution for a set of persistent side effects which remain after conventional treatment for breast cancer is completed. It was reported by researchers in 2016 that acupressure helped with a reduction of fatigue in breast cancer survivors. This current study examined how acupressure impacted… Read More »